Author: Claude (AI), from PubMed abstracts · Reviewed by: Dr Mina Abdelmseih · Reviewed: 2026-11-15 · Review due: 2027-11-15

Educational content only. Not personalised medical advice. Clinical decisions remain the responsibility of the treating clinician.

Visual acuity testing: charts, apps and children

Visual acuity (VA) is the simplest and most used assessment of visual function, and chart design and testing procedure affect how reliable and valid the result is [S12]. Measurement variability in adults is larger than often assumed [S10], and smartphone, web and printed home tests now extend testing beyond the clinic, with uneven validation [S3] [S9] [S11].

Key points - Distance VA in adults varies by about ±0.20 logMAR between measurements (very low certainty evidence), wider than the commonly quoted ±0.15 logMAR [S10]. - Charts based on Bailey-Lovie design principles used with standardised protocols may reduce test-retest variability [S12]. - In children aged 3 to 4 years, Lea symbols gave better acuity than a tumbling E chart and are preferred for this age group [S1]; grating acuity tests serve infants and people who cannot respond verbally [S8]. - Mobile app VA tests showed pooled sensitivity of 0.85 to 0.87 against clinical tests across age groups in a meta-analysis [S5], but few apps have been clinically validated [S4] [S11]. - Peek Acuity had the strongest supporting evidence among home tests in one systematic review [S3]; another found most remote self-tests less accurate than clinic assessment [S9].

Evidence last checked: 2026-10-17 (PubMed abstracts).

Red flags: results that need action now

• A drop of 2 lines or more from a previous reliable measurement. One validation study treated a change of 0.2 logMAR or more as significant [S6]; because test-retest variability is about ±0.20 logMAR [S10], repeat the test carefully, then act on a confirmed drop.
• Sudden painless or painful loss of vision in one eye. Needs same-day eye assessment.
• A young child who cannot fixate or follow, or has unequal acuity between the eyes. Use an age-appropriate test [S1] [S8] and refer (see below).
• A normal high-contrast acuity in an older patient with visual complaints. Standard VA does not assess low-contrast vision, which matters for mobility in the elderly [S12].

Recognise it: what acuity tells you

• Reduced acuity may come from optical blur or from disease of the macula and visual pathways [S12].
• Acuity improves rapidly in the first year of life and reaches adult levels at about 4 to 6 years or later; in healthy eyes it then typically stays stable until the eighth decade [S12].
• Hyperacuity measures show promise for assessing macular function [S12].

Confirm it: getting a reliable measurement

• Adults. Use a logMAR-type chart with a standard protocol where available [S12]. Treat changes within about ±0.20 logMAR as possibly within measurement noise [S10].
• Preschool children. In 47 children aged 3 to 6 years, mean logMAR was 0.17 with Lea symbols and 0.22 with the Bailey-Lovie tumbling E; the difference was significant at 3 to 4 years but not at 5 to 6 years [S1].
• Infants, young children and people with disabilities. A review identified eight grating acuity tests (six paper-based, two app-based); repeatability data existed for only four [S8].
• Screening context. In preschool screening studies, inability to cooperate may limit some tests below age 3, and with low prevalence (<10%) false-positive rates were high (usually >75%) [S2].

Manage it: testing at each resource tier

Before acting on this section, check the national and local guidelines, product information and regulatory approvals that apply where you practise. See the medical disclaimer.

Tier A (primary care / no specialist)

1. A printed chart or a validated smartphone app is a practical option. In 22 studies of tablet or smartphone apps, a meta-analysis of 6 studies (24,284 participants) found pooled sensitivity of 0.87 and specificity of 0.78 in children aged 3 to 5 years, and 0.86 and 0.91 in those aged 6 to 22 years [S5].
2. Non-professional examiners achieved high accuracy with apps (AUC 0.93 vs 0.87 for professionals) [S5], which supports task-sharing with trained lay workers.
3. Choose a validated app. Of 24 free apps surveyed in 2021, only 5 calibrated optotype size and 3 had evidence of clinical validation [S4]. A 2025 review of 44 apps found few clinically validated and a mean quality score of about 3 out of 5 [S11].
4. Peek Acuity on a smartphone showed a mean difference of 0.055 logMAR from ETDRS for home testing, with test-retest variability of ±0.029 logMAR [S3].

Tier B (general eye clinic)

1. Measure with a standard chart under a consistent protocol and record logMAR where possible [S12].
2. For telehealth follow-up, home tests can be useful. In a randomised validation study of 121 adults, printed chart, phone app and website results were within 1 line of clinic Snellen acuity, with mean differences of -0.07, -0.12 and -0.13 logMAR; the printed chart correlated best (r = 0.72) [S6]. Older participants were more likely to have limited access to digital tools [S6].
3. For children, the Smart Optometry app had 89.3% sensitivity for subnormal VA and good caregiver-clinician agreement, but lower sensitivity for amblyopia [S7].

Tier C (specialist centre)

1. Use standardised logMAR protocols for monitoring and research, recognising that published variability limits rest on very low certainty evidence [S10].
2. Consider additional tests (contrast, hyperacuity) when standard acuity does not explain symptoms [S12].
3. Remote self-tests are promising for triage and long-term monitoring but need further pragmatic trials before wide deployment [S9].

Refer when

Pitfalls

• Treating a one-line change as real progression: variability is about ±0.20 logMAR [S10].
• Using a directional E test in 3 to 4 year olds instead of picture symbols [S1].
• Trusting any app: most are unvalidated and many lack size calibration [S4] [S11].
• Over-referring from low-prevalence screening: false-positive rates can exceed 75% [S2].
• Assuming normal acuity means normal function in the elderly [S12].
• Relying on app tests to detect amblyopia [S7].

Evidence notes

• The variability estimate rests on studies with high or unclear risk of bias [S10].
• Reviews of home testing conflict: one favours Peek Acuity [S3], another found conflicting results for Peek Acuity and iSight Professional in a pooled study [S9].
• The USPSTF review found no RCT comparing screening with no screening [S2].
• App reviews are snapshots of app stores and age quickly [S4] [S11].
• Not covered by these sources: near acuity standards, low-vision acuity charts, test distance and lighting standards, and acuity notation conversion tables.

Related articles

• Vision screening in children
• Low-vision rehabilitation

References

See the numbered source list below. Each marker [S#] links to its PubMed and DOI record.